|
End-of-day quote
Pakistan S.E.
16/11/2026
|
5-day change | 1st Jan Change | ||
| 339.59 PKR | +0.96% |
|
+0.68% | -12.88% |
| Market Cap | 108B 392M 356M 329M 297M 561M 36.79B 580M 3.96B 1.57B 19.74B 1.47B 1.44B 62.53B | P/E 2026 * |
10.2x | P/E 2027 * | 8.55x |
|---|---|---|---|---|---|
| Enterprise Value | 108B 392M 356M 329M 297M 561M 36.79B 580M 3.96B 1.57B 19.74B 1.47B 1.44B 62.53B | EV / Sales 2026 * |
1.57x | EV / Sales 2027 * | 1.48x |
| Free-Float |
16.89% | Yield 2026 * |
5.31% | Yield 2027 * | 5.74% |
| 1 day | +0.96% | ||
| 1 week | +0.68% | ||
| Current month | +6.32% | ||
| 1 month | +8.90% | ||
| 3 months | -1.48% | ||
| 6 months | -1.82% | ||
| Current year | -12.88% |
| 1 week | 335 | 347.39 | |
| 1 month | 305 | 347.39 | |
| Current year | 293.09 | 459.27 | |
| 1 year | 293.09 | 459.27 | |
| 3 years | 75.01 | 481 | |
| 5 years | 68 | 481 | |
| 10 years | 68 | 481 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01/03/2020 | |
Syed Alam
CTO | Chief Tech/Sci/R&D Officer | - | - |
Yousuf Khan
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 07/05/2011 | |
Maheen Rahman
BRD | Director/Board Member | - | 05/12/2018 |
Muneer Kamal
BRD | Director/Board Member | 72 | 02/04/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.96% | +0.68% | -13.75% | +315.55% | 387M | ||
| +0.13% | +2.54% | +41.71% | +145.92% | 1,286B | ||
| -0.17% | +1.04% | +42.81% | +89.89% | 688B | ||
| +0.56% | +1.24% | +26.90% | +114.74% | 521B | ||
| +1.14% | +2.04% | +42.51% | +72.81% | 386B | ||
| -0.77% | -1.39% | +57.97% | +43.83% | 364B | ||
| +1.27% | +1.72% | +28.34% | +63.11% | 302B | ||
| +0.37% | -0.23% | +3.25% | +38.05% | 287B | ||
| +0.49% | +0.75% | +37.16% | +74.24% | 252B | ||
| +0.82% | +0.17% | +36.68% | +127.60% | 208B | ||
| Average | +0.39% | +1.82% | +30.36% | +108.57% | 429B | |
| Weighted average by Cap. | +0.24% | +3.26% | +37.52% | +99.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 68.81B 249M 226M 209M 189M 356M 23.38B 369M 2.51B 996M 12.55B 934M 915M 39.74B | 73.23B 265M 241M 222M 201M 379M 24.88B 392M 2.67B 1.06B 13.35B 994M 973M 42.29B |
| Net income | 10.49B 37.96M 34.48M 31.86M 28.78M 54.31M 3.56B 56.22M 383M 152M 1.91B 142M 139M 6.06B | 12.43B 44.98M 40.86M 37.76M 34.1M 64.36M 4.22B 66.62M 454M 180M 2.27B 169M 165M 7.18B |
| Net Debt | - | - |
Employees
1,606
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/11/26 | PKR 339.59 | +0.96% | 118,978 |
| 13/11/26 | PKR 336.36 | -0.57% | 97,426 |
| 12/11/26 | PKR 338.29 | -0.94% | 107,149 |
| 11/11/26 | PKR 341.49 | +0.05% | 267,402 |
| 10/11/26 | PKR 341.33 | +1.19% | 136,549 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
339.59PKR
Average target price
510.00PKR
Spread / Average Target
+50.18%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
















